Cargando…
Comparison between fluoropyrimidine-hepatic arterial infusion and systemic chemotherapy for unresectable liver metastases: A protocol for systematic review and meta-analysis based on 16 observational studies
BACKGROUND: The benefit of loco-regional treatments such as hepatic arterial infusion (HAI) in terms of survival and response rate is unclear. The aim of this work is to quantitatively summarize the results of both randomized controlled trials (RCTs) and non-randomized studies of interventions (NRSI...
Autores principales: | Zhao, Jianmeng, Zheng, Yuenan, Liu, Tao, Chang, Jinzhe, Shan, Hongqing, Cong, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519215/ https://www.ncbi.nlm.nih.gov/pubmed/34731127 http://dx.doi.org/10.1097/MD.0000000000027483 |
Ejemplares similares
-
The prognostic significance of LTBP2 for malignant tumors: Evidence based on 11 observational studies
por: Zhao, Jianmeng, et al.
Publicado: (2022) -
Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature
por: Mitani, Seiichiro, et al.
Publicado: (2017) -
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab
por: Basso, Michele, et al.
Publicado: (2016) -
Feasibility of (125)I brachytherapy combined with arterial infusion chemotherapy in patients with advanced pancreatic cancer
por: Huang, Shujing, et al.
Publicado: (2023) -
The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy
por: Yeom, Seung-Seop, et al.
Publicado: (2020)